Nykøbing F. Sygehus er et hospital i Nykøbing Falster i Region Sjælland. Hospitalet dækker især Guldborgsund Kommune og er beliggende i den nordlige del af byen ud til Guldborg Sund. Nykøbing F.

During the past decade, Nykøbing Falster Hospital conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nykøbing Falster Hospital" #1 sponsor was "Celgene" with 3 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Karolinska Institutet" with 2 trials sponsored, "Soren Overgaard" with 2 trials sponsored and "Daiichi Sankyo, Inc." with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nykøbing Falster Hospital" #1 collaborator was "Aarhus University Hospital" with 5 trials as a collaborator, "Odense University Hospital" with 4 trials as a collaborator, "Sygehus Lillebaelt" with 3 trials as a collaborator, "Copenhagen Trial Unit, Center for Clinical Intervention Research" with 2 trials as a collaborator and "Herlev Hospital" with 2 trials as a collaborator. Other collaborators include 53 different institutions and companies that were collaborators in the rest 55 trials.

According to Clinical.Site data, the most researched conditions in "Nykøbing Falster Hospital" are "Crohn Disease" (4 trials), "Prosthetic-joint Infection" (2 trials), "Total Hip Arthroplasty" (2 trials), "Acute Disease" (1 trials) and "Airway Management" (1 trials). Many other conditions were trialed in "Nykøbing Falster Hospital" in a lesser frequency.

Most popular intervention types in "Nykøbing Falster Hospital" are "Drug" (9 trials), "Other" (5 trials), "Procedure" (4 trials), "Biological" (2 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Ozanimod" (3 trials), "Antibiotic dosage practice" (2 trials), "Golimumab" (2 trials) and "Guselkumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Nykøbing Falster Hospital" are 17 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Nykøbing Falster Hospital". undefined are not yet recruiting, 13 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Nykøbing Falster Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nykøbing Falster Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 10 trials that are defined as “Not Applicable".